Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to -$0.16.

  • ProPhase Labs' EPS (Basic) rose 5428.57% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.99, marking a year-over-year decrease of 2838.71%. This contributed to the annual value of -$0.19 for FY2024, which is 8085.64% up from last year.
  • As of Q3 2025, ProPhase Labs' EPS (Basic) stood at -$0.16, which was up 5428.57% from -$0.11 recorded in Q2 2025.
  • ProPhase Labs' 5-year EPS (Basic) high stood at $0.81 for Q1 2022, and its period low was -$0.51 during Q4 2023.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.13 (2025), whereas its average is -$0.04.
  • As far as peak fluctuations go, ProPhase Labs' EPS (Basic) soared by 2019125.0% in 2021, and later crashed by 130000.0% in 2024.
  • Quarter analysis of 5 years shows ProPhase Labs' EPS (Basic) stood at $0.7 in 2021, then tumbled by 122.86% to -$0.16 in 2022, then crashed by 218.75% to -$0.51 in 2023, then skyrocketed by 92.47% to -$0.04 in 2024, then tumbled by 316.55% to -$0.16 in 2025.
  • Its EPS (Basic) stands at -$0.16 for Q3 2025, versus -$0.11 for Q2 2025 and -$0.13 for Q1 2025.